Click on a field for details on how to access that data via Web API, Excel, or CSV File Download.
| Open Price | |
| High Price | |
| Low Price | |
| Close Price | |
| Change | |
| Percent Change | |
| Volume |
| Avg Daily Volume | N/A |
| 52 Week High | $10.25 |
| 52 Week Low | $9.87 |
| Target Price | N/A |
| Ticker | EUCR:UW |
| Composite Ticker | EUCR:US |
| Security Name | Eucrates Biomedical Acquisition Corp |
| Type | Ordinary Shares |
| Class | EUCR |
| Currency | USD |
| Round Lot Size | N/A |
| Primary | Yes |
| Delisted | No |
| ETF | No |
| Market Category | Common Stock |
| Market Sector | Equity |
| Exchange Symbol | ^USCOMP |
| Exchange Name | US COMPOSITE |
| Exchange City | N/A |
| Exchange Country | UNITED STATES OF AMERICA |
| Exchange Website | N/A |
| FIGI | BBG00YN6ZR80 |
| Composite FIGI | BBG00XVBK3S9 |
| Share Class FIGI | BBG00XVBK3T8 |
| FIGI Unique ID | N/A |
| Dividend | N/A |
| Dividend Rate | N/A |
| Trailing Dividend Yield | 0.00% |
| 5-year Average Dividend Yield | 0.00% |
| Dividend Ex Date | N/A |
| Beta | 0.2024 |
| 1-year beta | -2.8037 |
| 3-year beta | 0.2024 |
| 5-year beta | 0.2024 |
| 7-year beta | 0.2024 |
| 10-year beta | 0.2024 |
Eucrates Biomedical Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
